Cargando…

Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation

BACKGROUND: Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swaminathan, Subramanian, Perumal, Vanamail, Adinarayanan, Srividya, Kaliannagounder, Krishnamoorthy, Rengachari, Ravi, Purushothaman, Jambulingam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510097/ https://www.ncbi.nlm.nih.gov/pubmed/23209865 http://dx.doi.org/10.1371/journal.pntd.0001926

Ejemplares similares

Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India
por: Subramanian, Swaminathan, et al.
Publicado: (2020)

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects
por: Swaminathan, Subramanian, et al.
Publicado: (2008)

Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review
por: Srividya, Adinarayanan, et al.
Publicado: (2019)

Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India
por: Subramanian, Swaminathan, et al.
Publicado: (2017)

Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India
por: Dinesh, Raja Jeyapal, et al.
Publicado: (2023)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Molecular xenomonitoring of diurnally subperiodic Wuchereria bancrofti infection in Aedes (Downsiomyia) niveus (Ludlow, 1903) after nine rounds of Mass Drug Administration in Nancowry Islands, Andaman and Nicobar Islands, India
por: Premkumar, Addepalli, et al.
Publicado: (2020)

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
por: Jambulingam, Purushothaman, et al.
Publicado: (2022)

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
por: Weil, Gary J., et al.
Publicado: (2019)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India
por: Sabesan, S., et al.
Publicado: (2022)

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
por: Simonsen, Paul E, et al.
Publicado: (2014)

Delimitation of lymphatic filariasis transmission risk areas: a geo-environmental approach
por: Sabesan, Shanmugavelu, et al.
Publicado: (2006)

Probable sociobehavioural and environmental risk factors for dengue transmission in Puducherry, India – An exploratory study
por: Jeyapal, Dinesh Raja, et al.
Publicado: (2022)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach
por: Goss, Charles W., et al.
Publicado: (2019)

No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience
por: Nandha, B, et al.
Publicado: (2007)

Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2013)

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission
por: Simonsen, Paul E, et al.
Publicado: (2013)

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar
por: Dickson, Benjamin F. R., et al.
Publicado: (2018)

Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Evaluation of long-lasting indoor residual spraying of deltamethrin 62.5 SC-PE against malaria vectors in India
por: Sahu, Sudhansu Sekhar, et al.
Publicado: (2020)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Lymphatic filariasis: A view at pathological diversity
por: Mahalingashetti, Prashant Basavaraj, et al.
Publicado: (2014)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania
por: Lupenza, Eliza, et al.
Publicado: (2021)

Lymphatic Filariasis Elimination Status: Wuchereria bancrofti Infections in Human Populations after Five Effective Rounds of Mass Drug Administration in Zambia
por: Matapo, Belem Blamwell, et al.
Publicado: (2023)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Persistent foci of falciparum malaria among tribes over two decades in Koraput district of Odisha State, India
por: Sahu, Sudhansu Sekhar, et al.
Publicado: (2013)

Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control
por: Njenga, Sammy M, et al.
Publicado: (2011)

Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration
por: Derua, Yahya A., et al.
Publicado: (2018)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_teberhocmk463e4j7phr82fqi5